Compare US HB 1927 (2021) and US SB 777 (2021)
The introduced text of these two bills, side by side, with the wording they share.
- US HB 1927 (2021) · U.S. Congress · 2021 · Failed
- US SB 777 (2021) · U.S. Congress · 2021 · Failed
1,013 shared 8-word phrases found in the introduced text of these two bills.
This highlights wording the two bills share in their introduced text. A shared passage may include text that both bills quote from the same existing law, not only language either one drafted. A match shows that the texts overlap; it does not show who drafted a bill, and filing order alone does not show which bill copied which.
| US HB 1927 (2021) | US SB 777 (2021) |
|---|---|
| To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes. IN THE | To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes. IN THE |
| A BILL To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 3 (a) SHORT TITLE.—This Act may be cited as the 4 ‘‘End Taxpayer Funding of Gender Experimentation Act 5 of | A BILL To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 3 (a) SHORT TITLE.—This Act may be cited as the 4 ‘‘End Taxpayer Funding of Gender Experimentation Act 5 of |
| b) TABLE OF CONTENTS.—The table of contents of 1 this Act is as follows: 2 Sec. 1. Short title; table of contents. TITLE I—PROHIBITING FEDERALLY FUNDED GENDER REASSIGNMENT MEDICAL INTERVENTIONS | b) TABLE OF CONTENTS.—The table of contents of 7 this Act is as follows: 8 Sec. 1. Short title; table of contents. TITLE I—PROHIBITING FEDERALLY FUNDED GENDER REASSIGNMENT MEDICAL INTERVENTIONS |
| Sec. 101. Prohibiting taxpayer-funded gender reassignment medical interven- tions. Sec. 102. Amendment to table of chapters. TITLE II—APPLICATION UNDER THE AFFORDABLE CARE ACT Sec. 201. Clarifying application of prohibition to premium credits and cost- sharing reductions under ACA. TITLE I—PROHIBITING FEDER- 3 ALLY FUNDED GENDER REAS- 4 SIGNMENT MEDICAL INTER- 5 VENTIONS 6 SEC. 101. PROHIBITING TAXPAYER-FUNDED GENDER REAS- 7 SIGNMENT MEDICAL INTERVENTIONS. 8 Title 1, United States Code, is amended by adding 9 at the end the following new chapter: 10 ‘‘CHAPTER 4—PROHIBITING TAXPAYER- 11 FUNDED GENDER REASSIGNMENT 12 MEDICAL INTERVENTIONS 13 ‘‘301. Prohibition on funding for gender reassignme… | Sec. 101. Prohibiting taxpayer-funded gender reassignment medical interven- tions. Sec. 102. Amendment to table of chapters. TITLE II—APPLICATION UNDER THE AFFORDABLE CARE ACT Sec. 201. Clarifying application of prohibition to premium credits and cost- sharing reductions under ACA. TITLE I—PROHIBITING FEDER- 1 ALLY FUNDED GENDER REAS- 2 SIGNMENT MEDICAL INTER- 3 VENTIONS 4 SEC. 101. PROHIBITING TAXPAYER-FUNDED GENDER REAS- 5 SIGNMENT MEDICAL INTERVENTIONS. 6 Title 1, United States Code, is amended by adding 7 at the end the following new chapter: 8 ‘‘CHAPTER 4—PROHIBITING TAXPAYER- 9 FUNDED GENDER REASSIGNMENT 10 MEDICAL INTERVENTIONS 11 ‘‘301. Prohibition on funding for gender reassignment… |
| Prohibition on funding for gender reassign- 1 ment medical interventions 2 ‘‘No funds authorized or appropriated by Federal 3 law, and none of the funds in any trust fund to which 4 funds are authorized or appropriated by Federal law, shall | Prohibition on funding for gender reassign- 12 ment medical interventions 13 ‘‘No funds authorized or appropriated by Federal 14 law, and none of the funds in any trust fund to which 15 funds are authorized or appropriated by Federal law, shall |
| authorized or appropriated by Federal law, shall 5 be expended for | authorized or appropriated by Federal law, shall 8 be expended for |
| by Federal law, shall 13 be expended for health benefits coverage that includes cov- 14 erage of gender reassignment medical interventions. 15 ‘‘§ 303. Limitation on Federal facilities and employees 16 ‘‘No health care service furnished— 17 ‘‘(1) by or in a health care facility owned or op- 18 erated by the Federal Government; or 19 ‘‘(2) by any physician or other individual em- 20 ployed by the Federal Government to provide health 21 care services within the scope of the physician’s or 22 individual’s employment, 23 may include gender reassignment medical interventions | by Federal law, shall 8 be expended for health benefits coverage that includes cov- 9 erage of gender reassignment medical interventions. 10 ‘‘§ 303. Limitation on Federal facilities and employees 11 ‘‘No health care service furnished— 12 ‘‘(1) by or in a health care facility owned or op- 13 erated by the Federal Government; or 14 ‘‘(2) by any physician or other individual em- 15 ployed by the Federal Government to provide health 16 care services within the scope of the physician’s or 17 individual’s employment, 18 may include gender reassignment medical interventions |
| Construction relating to separate coverage 1 ‘‘Nothing in this chapter shall be construed as pro- 2 hibiting any individual, entity, or State or locality from 3 purchasing separate coverage for gender reassignment 4 medical interventions or health benefits coverage that in- 5 cludes gender reassignment medical interventions so long | Construction relating to separate coverage 20 ‘‘Nothing in this chapter shall be construed as pro- 21 hibiting any individual, entity, or State or locality from 22 purchasing separate coverage for gender reassignment 23 medical interventions or health benefits coverage that in- 24 cludes gender reassignment medical interventions so long |
| as such coverage is paid for entirely using only funds not 7 authorized or appropriated by Federal law and such cov- 8 erage shall not be purchased using matching funds re- 9 quired for a federally subsidized program, including a 10 State’s or locality’s contribution of Medicaid matching 11 funds. 12 ‘‘§ 305. Construction relating to the use of non-Fed- 13 eral funds for health coverage 14 ‘‘Nothing in this chapter shall be construed as re- 15 stricting the ability of any non-Federal health benefits cov- 16 erage provider from offering coverage for gender reassign- 17 ment medical interventions, or the ability of a State or 18 locality to contract separately with such a provider for 19 such… | as such coverage is paid for entirely using only funds not 1 authorized or appropriated by Federal law and such cov- 2 erage shall not be purchased using matching funds re- 3 quired for a federally subsidized program, including a 4 State’s or locality’s contribution of Medicaid matching 5 funds. 6 ‘‘§ 305. Construction relating to the use of non-Fed- 7 eral funds for health coverage 8 ‘‘Nothing in this chapter shall be construed as re- 9 stricting the ability of any non-Federal health benefits cov- 10 erage provider from offering coverage for gender reassign- 11 ment medical interventions, or the ability of a State or 12 locality to contract separately with such a provider for 13 such cover… |
| Construction relating to complications arising 1 from gender reassignment medical inter- 2 ventions 3 ‘‘Nothing in this chapter shall be construed to apply 4 to the treatment of any infection, injury, disease, or dis- 5 order that has been caused by or exacerbated by the per- 6 formance of a gender reassignment medical intervention | Construction relating to complications arising 19 from gender reassignment medical inter- 20 ventions 21 ‘‘Nothing in this chapter shall be construed to apply 22 to the treatment of any infection, injury, disease, or dis- 23 order that has been caused by or exacerbated by the per- 24 formance of a gender reassignment medical intervention |
| This rule of construction shall be applicable without re- 8 gard to whether the gender reassignment medical inter- 9 vention was performed in accord with Federal or State 10 law, and without regard to whether funding for the gender 11 reassignment medical intervention is permissible under 12 section 307. 13 ‘‘§ 307. Treatment of individuals born with medically 14 verifiable disorder of sex development 15 ‘‘The limitations established in sections 301, 302, 16 and 303 shall not apply with respect to the following indi- 17 viduals: 18 ‘‘(1) An individual with external biological sex 19 characteristics that are irresolvably ambiguous, such 20 as those born with 46 XX chromosomes with viriliza-… | This rule of construction shall be applicable without re- 1 gard to whether the gender reassignment medical inter- 2 vention was performed in accord with Federal or State 3 law, and without regard to whether funding for the gender 4 reassignment medical intervention is permissible under 5 section 307. 6 ‘‘§ 307. Treatment of individuals born with medically 7 verifiable disorder of sex development 8 ‘‘The limitations established in sections 301, 302, 9 and 303 shall not apply with respect to the following indi- 10 viduals: 11 ‘‘(1) An individual with external biological sex 12 characteristics that are irresolvably ambiguous, such 13 as those born with 46 XX chromosomes with 14 virilization,… |
| chromosome structure, sex steroid hormone produc- 1 tion, or sex steroid hormone action for a biological 2 male or female | chromosome structure, sex steroid hormone produc- 21 tion, or sex steroid hormone action for a biological 22 male or female |
| Gender reassignment medical intervention de- 4 fined 5 ‘‘For purposes of this chapter, the term ‘gender reas- 6 signment medical intervention’ means— 7 ‘‘(1) performing a surgery that sterilizes an in- 8 dividual, including castration, vasectomy | Gender reassignment medical intervention de- 1 fined 2 ‘‘For purposes of this chapter, the term ‘gender reas- 3 signment medical intervention’ means— 4 ‘‘(1) performing a surgery that sterilizes an in- 5 dividual, including castration, vasectomy |
| and vaginoplasty, to change the body of 11 such individual to correspond to a sex that is dis- 12 cordant with biological sex; 13 ‘‘(2) performing a mastectomy on an individual 14 for the purpose described in paragraph (1); and 15 ‘‘(3) administering or supplying to an individual 16 medications for the purpose described in paragraph 17 (1), including— 18 ‘‘(A) GnRH agonists or other puberty- 19 blocking drugs to stop or delay normal puberty; 20 ‘‘(B) testosterone or other androgens to bi- 21 ological females at doses that are supraphysio- 22 logic to the female sex; and 23 ‘‘(C) estrogen to biological males at doses 24 that are supraphysiologic to the male sex | and vaginoplasty, to change 8 the body of such individual to correspond to a sex 9 that is discordant with biological sex; 10 ‘‘(2) performing a mastectomy on an individual 11 for the purpose described in paragraph (1); and 12 ‘‘(3) administering or supplying to an individual 13 medications for the purpose described in paragraph 14 (1), including— 15 ‘‘(A) GnRH agonists or other puberty- 16 blocking drugs to stop or delay normal puberty; 17 ‘‘(B) testosterone or other androgens to bi- 18 ological females at doses that are 19 supraphysiologic to the female sex; and 20 ‘‘(C) estrogen to biological males at doses 21 that are supraphysiologic to the male sex |
| SEC. 102. AMENDMENT TO TABLE OF CHAPTERS. 1 The table of chapters for title 1, United States Code, 2 is amended by adding at the end the following new item | SEC. 102. AMENDMENT TO TABLE OF CHAPTERS. 23 The table of chapters for title 1, United States Code, 24 is amended by adding at the end the following new item |
Only the first shared passages are listed here; the side-by-side view shows them all.